

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85640170 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.66780960 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66780960 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49528603 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.49528603 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.30287763 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.29994681 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.29994681 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.29994681 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.29994681 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.29994681 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.29994681 |
| 13 | positive regulation of histone deacetylation (GO:0031065) | 4.17952359 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.14569484 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.07371054 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94368038 |
| 17 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.67509405 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57582122 |
| 19 | germinal center formation (GO:0002467) | 3.57215018 |
| 20 | tolerance induction (GO:0002507) | 3.48707788 |
| 21 | detection of other organism (GO:0098543) | 3.47974099 |
| 22 | detection of bacterium (GO:0016045) | 3.47553831 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45176172 |
| 24 | leukocyte aggregation (GO:0070486) | 3.41755058 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.34979766 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.34571374 |
| 27 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.34075271 |
| 28 | thymic T cell selection (GO:0045061) | 3.32088771 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 3.28535968 |
| 30 | mannose metabolic process (GO:0006013) | 3.26956852 |
| 31 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.20402894 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.19471923 |
| 33 | positive T cell selection (GO:0043368) | 3.19402006 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.12545722 |
| 35 | T cell selection (GO:0045058) | 3.11963244 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08561464 |
| 37 | response to laminar fluid shear stress (GO:0034616) | 3.07343497 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05071505 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.04993748 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93229818 |
| 41 | response to muramyl dipeptide (GO:0032495) | 2.91187198 |
| 42 | detection of external biotic stimulus (GO:0098581) | 2.90775240 |
| 43 | positive regulation of protein deacetylation (GO:0090312) | 2.87363367 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 2.86300730 |
| 45 | negative T cell selection (GO:0043383) | 2.85475414 |
| 46 | negative thymic T cell selection (GO:0045060) | 2.85249929 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 2.83937484 |
| 48 | cellular extravasation (GO:0045123) | 2.78264707 |
| 49 | modulation by symbiont of host cellular process (GO:0044068) | 2.76638988 |
| 50 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75519160 |
| 51 | natural killer cell differentiation (GO:0001779) | 2.75094240 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 2.74114731 |
| 53 | modulation by virus of host process (GO:0019054) | 2.73740841 |
| 54 | regulation of histone H3-K27 methylation (GO:0061085) | 2.71738351 |
| 55 | neutrophil activation (GO:0042119) | 2.71064017 |
| 56 | granulocyte activation (GO:0036230) | 2.70981698 |
| 57 | negative regulation of granulocyte differentiation (GO:0030853) | 2.69301103 |
| 58 | regulation of erythrocyte differentiation (GO:0045646) | 2.69095338 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68062855 |
| 60 | cellular response to zinc ion (GO:0071294) | 2.67788231 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66725041 |
| 62 | response to peptidoglycan (GO:0032494) | 2.66567071 |
| 63 | leukocyte cell-cell adhesion (GO:0007159) | 2.65946553 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 2.64086177 |
| 65 | growth hormone receptor signaling pathway (GO:0060396) | 2.63930869 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 2.62073903 |
| 67 | positive regulation of interferon-alpha production (GO:0032727) | 2.61410263 |
| 68 | histone H3-K36 demethylation (GO:0070544) | 2.60126172 |
| 69 | detection of molecule of bacterial origin (GO:0032490) | 2.59372402 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.59289313 |
| 71 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58078490 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.57529013 |
| 73 | detection of biotic stimulus (GO:0009595) | 2.57166976 |
| 74 | negative regulation of stress fiber assembly (GO:0051497) | 2.54958692 |
| 75 | myeloid dendritic cell differentiation (GO:0043011) | 2.54555657 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.54520031 |
| 77 | response to host immune response (GO:0052572) | 2.54520031 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53209174 |
| 79 | mature B cell differentiation (GO:0002335) | 2.53200192 |
| 80 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.52031071 |
| 81 | regulation of interferon-alpha production (GO:0032647) | 2.51983248 |
| 82 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.50648135 |
| 83 | response to type I interferon (GO:0034340) | 2.49666238 |
| 84 | response to host (GO:0075136) | 2.49361472 |
| 85 | response to host defenses (GO:0052200) | 2.49361472 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49361472 |
| 87 | regulation of necroptotic process (GO:0060544) | 2.49267466 |
| 88 | protein localization to endosome (GO:0036010) | 2.48763647 |
| 89 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.48372484 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 2.48109443 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47510513 |
| 92 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.47301095 |
| 93 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47007230 |
| 94 | negative regulation of interleukin-6 production (GO:0032715) | 2.46205765 |
| 95 | signal complex assembly (GO:0007172) | 2.44190965 |
| 96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44041490 |
| 97 | regulation of tolerance induction (GO:0002643) | 2.43111296 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.42937792 |
| 99 | T cell migration (GO:0072678) | 2.42797230 |
| 100 | positive regulation of type 2 immune response (GO:0002830) | 2.42570965 |
| 101 | megakaryocyte development (GO:0035855) | 2.42406502 |
| 102 | activation of JUN kinase activity (GO:0007257) | 2.42144179 |
| 103 | defense response to protozoan (GO:0042832) | 2.41634253 |
| 104 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.41578617 |
| 105 | embryonic process involved in female pregnancy (GO:0060136) | 2.41399849 |
| 106 | cortical actin cytoskeleton organization (GO:0030866) | 2.40961795 |
| 107 | regulation of integrin activation (GO:0033623) | 2.40634497 |
| 108 | I-kappaB phosphorylation (GO:0007252) | 2.40611944 |
| 109 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.40010982 |
| 110 | regulation of ARF GTPase activity (GO:0032312) | 2.39087771 |
| 111 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.37014756 |
| 112 | cellular response to growth hormone stimulus (GO:0071378) | 2.36715556 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.36432164 |
| 114 | type I interferon signaling pathway (GO:0060337) | 2.36432164 |
| 115 | response to protozoan (GO:0001562) | 2.35515639 |
| 116 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.35454201 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 2.35407453 |
| 118 | histone H3-K4 trimethylation (GO:0080182) | 2.35251460 |
| 119 | stress fiber assembly (GO:0043149) | 2.34991311 |
| 120 | response to interleukin-15 (GO:0070672) | 2.34291033 |
| 121 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.34221597 |
| 122 | myeloid cell activation involved in immune response (GO:0002275) | 2.33262949 |
| 123 | regulation of histone deacetylation (GO:0031063) | 2.32717269 |
| 124 | B cell homeostasis (GO:0001782) | 2.32693733 |
| 125 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.31303720 |
| 126 | positive regulation of tolerance induction (GO:0002645) | 2.30910816 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.30603246 |
| 128 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.30447999 |
| 129 | interferon-gamma production (GO:0032609) | 2.29392960 |
| 130 | respiratory burst (GO:0045730) | 2.29220491 |
| 131 | germ cell migration (GO:0008354) | 2.28845758 |
| 132 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.28737314 |
| 133 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.28036873 |
| 134 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.27363696 |
| 135 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.26906820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.59519144 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.55557743 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.51630287 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.51486842 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.22009781 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.19757104 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08940965 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93558474 |
| 9 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.77440799 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61496034 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58915719 |
| 12 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.58868087 |
| 13 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.54233979 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.52265257 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51816191 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41372328 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.39345210 |
| 18 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.37224100 |
| 19 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.34573781 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32637123 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.31912291 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.21079462 |
| 23 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.20296237 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19788372 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13428249 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09148133 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05854837 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03580424 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01563748 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95249250 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92586855 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90408712 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.88624312 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87598808 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85158141 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81284752 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.79997964 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78347151 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77246740 |
| 40 | * MYB_26560356_Chip-Seq_TH1_Human | 1.75348543 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71916843 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67082161 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65953655 |
| 44 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.65907402 |
| 45 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60241151 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57495339 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56496955 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.55974434 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55378285 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52979199 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50543374 |
| 52 | * P68_20966046_ChIP-Seq_HELA_Human | 1.50399402 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48741207 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46962828 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45148015 |
| 56 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.44478010 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43616040 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40058574 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35302242 |
| 60 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.33879899 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33045702 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31645128 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30335484 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29022096 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27992890 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26803763 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25852029 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25396267 |
| 69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24384901 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22418408 |
| 71 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22110731 |
| 72 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20311155 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19975141 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19154715 |
| 75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18961187 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18795349 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18513674 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17639867 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17468113 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17055308 |
| 81 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16654594 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16040296 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12562373 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12030537 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11008451 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10301683 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10064779 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08371897 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08324441 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05831045 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05506867 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04761573 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04376174 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02620516 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02143010 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00359713 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00088284 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99350443 |
| 99 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98277460 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97840907 |
| 101 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97160530 |
| 102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95978418 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95831421 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95322813 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95213328 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95129808 |
| 107 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94453891 |
| 108 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93213968 |
| 109 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93102029 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92759037 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92346268 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92114328 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91860397 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91699592 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91488819 |
| 116 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90809809 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90338566 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89991674 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88903360 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88796743 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88267184 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87703471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.88431974 |
| 2 | MP0009278_abnormal_bone_marrow | 3.24364189 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.17079324 |
| 4 | MP0001790_abnormal_immune_system | 2.88904518 |
| 5 | MP0005387_immune_system_phenotype | 2.88904518 |
| 6 | MP0003436_decreased_susceptibility_to | 2.88900499 |
| 7 | MP0000685_abnormal_immune_system | 2.84253483 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.83641131 |
| 9 | MP0005451_abnormal_body_composition | 2.62700587 |
| 10 | MP0001800_abnormal_humoral_immune | 2.58347976 |
| 11 | MP0004510_myositis | 2.55364315 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.29023810 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.27232859 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.26696746 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.23802510 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.23802510 |
| 17 | MP0004947_skin_inflammation | 2.22909700 |
| 18 | MP0002723_abnormal_immune_serum | 2.10709380 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.10670910 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.03598317 |
| 21 | MP0001819_abnormal_immune_cell | 2.02652404 |
| 22 | MP0002419_abnormal_innate_immunity | 2.01537198 |
| 23 | MP0005025_abnormal_response_to | 2.00769648 |
| 24 | MP0005671_abnormal_response_to | 1.97264750 |
| 25 | MP0002398_abnormal_bone_marrow | 1.96548981 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.94758282 |
| 27 | MP0006082_CNS_inflammation | 1.94433663 |
| 28 | MP0002405_respiratory_system_inflammati | 1.93568029 |
| 29 | MP0008260_abnormal_autophagy | 1.93343585 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.88208057 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.86296558 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.85468884 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.76364717 |
| 34 | MP0000716_abnormal_immune_system | 1.74153416 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.73204297 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.72099907 |
| 37 | MP0009785_altered_susceptibility_to | 1.68890681 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.66899315 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.65879509 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.62872476 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.61950370 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.59089138 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.57498057 |
| 44 | MP0002722_abnormal_immune_system | 1.55467446 |
| 45 | MP0005310_abnormal_salivary_gland | 1.49828266 |
| 46 | MP0009840_abnormal_foam_cell | 1.49035169 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.48725859 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.47538017 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.44905273 |
| 50 | MP0002429_abnormal_blood_cell | 1.44284087 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.44231636 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.40873474 |
| 53 | MP0004381_abnormal_hair_follicle | 1.40338507 |
| 54 | MP0001873_stomach_inflammation | 1.39609422 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.39229251 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.38973103 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.37286845 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.33926620 |
| 59 | MP0002006_tumorigenesis | 1.33409861 |
| 60 | MP0005409_darkened_coat_color | 1.33401659 |
| 61 | MP0003448_altered_tumor_morphology | 1.31416998 |
| 62 | MP0003045_fibrosis | 1.29466811 |
| 63 | MP0003866_abnormal_defecation | 1.29344031 |
| 64 | MP0002132_abnormal_respiratory_system | 1.28852835 |
| 65 | MP0004858_abnormal_nervous_system | 1.27563246 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.26426793 |
| 67 | MP0002933_joint_inflammation | 1.21917048 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.21848123 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.21550329 |
| 70 | MP0003091_abnormal_cell_migration | 1.18809792 |
| 71 | MP0001853_heart_inflammation | 1.15243479 |
| 72 | MP0005023_abnormal_wound_healing | 1.14726791 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.13709070 |
| 74 | MP0001851_eye_inflammation | 1.12609837 |
| 75 | MP0000858_altered_metastatic_potential | 1.04886434 |
| 76 | MP0003828_pulmonary_edema | 1.04117231 |
| 77 | MP0002796_impaired_skin_barrier | 1.02987302 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.00527641 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.98226919 |
| 80 | MP0002254_reproductive_system_inflammat | 0.97215227 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.96735668 |
| 82 | MP0010307_abnormal_tumor_latency | 0.96580510 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.96147290 |
| 84 | MP0000733_abnormal_muscle_development | 0.96124358 |
| 85 | MP0008469_abnormal_protein_level | 0.96106445 |
| 86 | MP0003279_aneurysm | 0.95194112 |
| 87 | MP0003075_altered_response_to | 0.95157434 |
| 88 | MP0002249_abnormal_larynx_morphology | 0.94345178 |
| 89 | MP0000343_altered_response_to | 0.85668530 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.84178854 |
| 91 | MP0001849_ear_inflammation | 0.82167701 |
| 92 | MP0009764_decreased_sensitivity_to | 0.81072462 |
| 93 | MP0009931_abnormal_skin_appearance | 0.80327258 |
| 94 | MP0010630_abnormal_cardiac_muscle | 0.79563753 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.78410456 |
| 96 | MP0008004_abnormal_stomach_pH | 0.77035962 |
| 97 | MP0005390_skeleton_phenotype | 0.74044257 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.73478103 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.73394309 |
| 100 | MP0000490_abnormal_crypts_of | 0.73045872 |
| 101 | MP0001663_abnormal_digestive_system | 0.71467897 |
| 102 | MP0003724_increased_susceptibility_to | 0.71249984 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.70512990 |
| 104 | MP0009115_abnormal_fat_cell | 0.69864911 |
| 105 | MP0000604_amyloidosis | 0.68313828 |
| 106 | MP0002925_abnormal_cardiovascular_devel | 0.68246970 |
| 107 | MP0000249_abnormal_blood_vessel | 0.66810369 |
| 108 | MP0000609_abnormal_liver_physiology | 0.66717091 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.66309778 |
| 110 | MP0002928_abnormal_bile_duct | 0.65854287 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.65749918 |
| 112 | MP0002060_abnormal_skin_morphology | 0.65719239 |
| 113 | MP0005166_decreased_susceptibility_to | 0.64416745 |
| 114 | MP0003795_abnormal_bone_structure | 0.63249749 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.62555129 |
| 116 | MP0005670_abnormal_white_adipose | 0.62354046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.47640379 |
| 2 | Recurrent fungal infections (HP:0002841) | 3.73429621 |
| 3 | Autoimmune thrombocytopenia (HP:0001973) | 3.71827539 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.69498052 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.61134430 |
| 6 | Recurrent viral infections (HP:0004429) | 3.58899440 |
| 7 | Cellulitis (HP:0100658) | 3.52295336 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.50701355 |
| 9 | Nasal polyposis (HP:0100582) | 3.28234468 |
| 10 | Cerebral aneurysm (HP:0004944) | 3.21076916 |
| 11 | Colitis (HP:0002583) | 3.19903490 |
| 12 | Pustule (HP:0200039) | 3.11984595 |
| 13 | Inflammation of the large intestine (HP:0002037) | 3.11230332 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 3.08108214 |
| 15 | Increased IgE level (HP:0003212) | 3.07452099 |
| 16 | Chronic otitis media (HP:0000389) | 3.06318444 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 3.04583321 |
| 18 | Obstructive sleep apnea (HP:0002870) | 3.04204672 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98635752 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89383085 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.85696847 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 2.71433250 |
| 23 | T lymphocytopenia (HP:0005403) | 2.65779188 |
| 24 | Spontaneous hematomas (HP:0007420) | 2.65422224 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.63783987 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62509873 |
| 27 | Broad face (HP:0000283) | 2.62324426 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62155122 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62155122 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.58342397 |
| 31 | Recurrent skin infections (HP:0001581) | 2.57693069 |
| 32 | Papilloma (HP:0012740) | 2.57090372 |
| 33 | Verrucae (HP:0200043) | 2.57090372 |
| 34 | Stomatitis (HP:0010280) | 2.44568514 |
| 35 | Hematochezia (HP:0002573) | 2.43910264 |
| 36 | Meningitis (HP:0001287) | 2.43525712 |
| 37 | Obstructive lung disease (HP:0006536) | 2.42000232 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42000232 |
| 39 | Gingivitis (HP:0000230) | 2.41912551 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.40203199 |
| 41 | Increased density of long bones (HP:0006392) | 2.39985909 |
| 42 | Recurrent bronchitis (HP:0002837) | 2.39969937 |
| 43 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38584483 |
| 44 | Thin bony cortex (HP:0002753) | 2.37851933 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.36453697 |
| 46 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.35914654 |
| 47 | Emphysema (HP:0002097) | 2.35857680 |
| 48 | Vasculitis (HP:0002633) | 2.34956051 |
| 49 | Hyperacusis (HP:0010780) | 2.34287973 |
| 50 | Polycythemia (HP:0001901) | 2.33962276 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.32606269 |
| 52 | Optic neuritis (HP:0100653) | 2.32606269 |
| 53 | Myositis (HP:0100614) | 2.31277458 |
| 54 | Ulnar bowing (HP:0003031) | 2.27943574 |
| 55 | Myocardial infarction (HP:0001658) | 2.25094110 |
| 56 | Periodontitis (HP:0000704) | 2.22696422 |
| 57 | Leukocytosis (HP:0001974) | 2.18974027 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.16180235 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.15316335 |
| 60 | Disproportionate tall stature (HP:0001519) | 2.14993733 |
| 61 | Urticaria (HP:0001025) | 2.09826479 |
| 62 | Abnormality of T cells (HP:0002843) | 2.08908223 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.08133156 |
| 64 | Eosinophilia (HP:0001880) | 2.07623792 |
| 65 | Slow saccadic eye movements (HP:0000514) | 2.07072455 |
| 66 | Osteomyelitis (HP:0002754) | 2.03340184 |
| 67 | Macroorchidism (HP:0000053) | 2.02390180 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.02386953 |
| 69 | Purpura (HP:0000979) | 2.01726026 |
| 70 | Aortic aneurysm (HP:0004942) | 2.01717118 |
| 71 | Chest pain (HP:0100749) | 2.01205401 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.00758024 |
| 73 | Gingival bleeding (HP:0000225) | 2.00013794 |
| 74 | Gastrointestinal stroma tumor (HP:0100723) | 1.99923272 |
| 75 | Polygenic inheritance (HP:0010982) | 1.95844402 |
| 76 | Frequent falls (HP:0002359) | 1.94702552 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 1.94658145 |
| 78 | Fatigue (HP:0012378) | 1.93823129 |
| 79 | Restrictive lung disease (HP:0002091) | 1.93554004 |
| 80 | Peritonitis (HP:0002586) | 1.93523087 |
| 81 | Hypertensive crisis (HP:0100735) | 1.91686619 |
| 82 | Thyroiditis (HP:0100646) | 1.91364258 |
| 83 | IgM deficiency (HP:0002850) | 1.90175849 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85920925 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85920925 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85920925 |
| 87 | Spinal cord lesions (HP:0100561) | 1.85383901 |
| 88 | Syringomyelia (HP:0003396) | 1.85383901 |
| 89 | Mitral valve prolapse (HP:0001634) | 1.84580049 |
| 90 | Flat acetabular roof (HP:0003180) | 1.84307579 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83847880 |
| 92 | Mucopolysacchariduria (HP:0008155) | 1.83847880 |
| 93 | Cheilitis (HP:0100825) | 1.83760735 |
| 94 | Abnormal platelet function (HP:0011869) | 1.83131687 |
| 95 | Impaired platelet aggregation (HP:0003540) | 1.83131687 |
| 96 | Osteolytic defects of the hand bones (HP:0009699) | 1.83081796 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83081796 |
| 98 | Easy fatigability (HP:0003388) | 1.82957924 |
| 99 | Loss of speech (HP:0002371) | 1.80938589 |
| 100 | Petechiae (HP:0000967) | 1.80839097 |
| 101 | Long palpebral fissure (HP:0000637) | 1.80732627 |
| 102 | Malnutrition (HP:0004395) | 1.80215206 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 1.80081297 |
| 104 | Epistaxis (HP:0000421) | 1.78919251 |
| 105 | Arterial thrombosis (HP:0004420) | 1.78911139 |
| 106 | Hypochromic anemia (HP:0001931) | 1.78834813 |
| 107 | Sepsis (HP:0100806) | 1.77894496 |
| 108 | Vertebral compression fractures (HP:0002953) | 1.77525826 |
| 109 | Pulmonary infiltrates (HP:0002113) | 1.77143324 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77040279 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77040279 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77040279 |
| 113 | Abnormality of the thoracic spine (HP:0100711) | 1.76626307 |
| 114 | Dysostosis multiplex (HP:0000943) | 1.75944499 |
| 115 | Abnormality of the peritoneum (HP:0002585) | 1.75843998 |
| 116 | Increased serum ferritin (HP:0003281) | 1.75602556 |
| 117 | Increased connective tissue (HP:0009025) | 1.74987326 |
| 118 | Skin ulcer (HP:0200042) | 1.74344131 |
| 119 | Orchitis (HP:0100796) | 1.73426210 |
| 120 | Aneurysm (HP:0002617) | 1.72716408 |
| 121 | Encephalitis (HP:0002383) | 1.72292614 |
| 122 | Lymphopenia (HP:0001888) | 1.71865644 |
| 123 | Keratoconjunctivitis sicca (HP:0001097) | 1.71336607 |
| 124 | Shallow orbits (HP:0000586) | 1.70661619 |
| 125 | Amyloidosis (HP:0011034) | 1.70107928 |
| 126 | Hypertriglyceridemia (HP:0002155) | 1.69803420 |
| 127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69741868 |
| 128 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.69580031 |
| 129 | Persistence of primary teeth (HP:0006335) | 1.69575058 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.69105114 |
| 131 | Long eyelashes (HP:0000527) | 1.68976656 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.66712821 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.66653651 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.66579374 |
| 135 | B lymphocytopenia (HP:0010976) | 1.65706907 |
| 136 | Abnormality of B cell number (HP:0010975) | 1.65706907 |
| 137 | Thick nail (HP:0001805) | 1.64977801 |
| 138 | Bicuspid aortic valve (HP:0001647) | 1.64103990 |
| 139 | Abnormality of T cell physiology (HP:0011840) | 1.62707046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.95539455 |
| 2 | ERN1 | 3.92601886 |
| 3 | PRPF4B | 3.87723582 |
| 4 | CDK12 | 3.33266472 |
| 5 | MAP3K10 | 3.14673235 |
| 6 | TRIB3 | 2.91448214 |
| 7 | EPHB1 | 2.44772526 |
| 8 | SMG1 | 2.44095405 |
| 9 | EEF2K | 2.27099324 |
| 10 | SIK2 | 2.08130147 |
| 11 | TYK2 | 1.93453892 |
| 12 | ICK | 1.76244877 |
| 13 | GRK6 | 1.73164565 |
| 14 | TBK1 | 1.70777781 |
| 15 | STK10 | 1.65414339 |
| 16 | SIK1 | 1.64721966 |
| 17 | PKN2 | 1.62494640 |
| 18 | RIPK4 | 1.59095094 |
| 19 | IKBKE | 1.54686520 |
| 20 | JAK1 | 1.51672122 |
| 21 | JAK3 | 1.50994286 |
| 22 | ZAP70 | 1.49291842 |
| 23 | BMX | 1.48391225 |
| 24 | FGFR4 | 1.46974302 |
| 25 | TAOK2 | 1.46884340 |
| 26 | MAP3K3 | 1.46488813 |
| 27 | CSK | 1.44902416 |
| 28 | PTK6 | 1.43325344 |
| 29 | CAMK1G | 1.40248698 |
| 30 | TGFBR2 | 1.38382494 |
| 31 | HCK | 1.34906615 |
| 32 | TXK | 1.34829455 |
| 33 | TAOK3 | 1.33857122 |
| 34 | BTK | 1.33114290 |
| 35 | BLK | 1.32587353 |
| 36 | MAP3K14 | 1.31195681 |
| 37 | RIPK1 | 1.30895794 |
| 38 | DMPK | 1.30634191 |
| 39 | CAMK1D | 1.26271764 |
| 40 | CDC42BPA | 1.22597137 |
| 41 | TTN | 1.22278282 |
| 42 | TAOK1 | 1.20417848 |
| 43 | FGFR3 | 1.15789134 |
| 44 | LRRK2 | 1.13586936 |
| 45 | SYK | 1.12455834 |
| 46 | IKBKB | 1.12442874 |
| 47 | CHUK | 1.09340843 |
| 48 | CSF1R | 1.09271280 |
| 49 | KSR2 | 1.07978706 |
| 50 | ALK | 1.04918475 |
| 51 | PRKD2 | 1.03354614 |
| 52 | ITK | 1.03116529 |
| 53 | IRAK4 | 1.02332260 |
| 54 | HIPK2 | 1.01669927 |
| 55 | IRAK3 | 1.00213783 |
| 56 | PDPK1 | 0.98977424 |
| 57 | KIT | 0.97781114 |
| 58 | IRAK2 | 0.96602238 |
| 59 | CDK6 | 0.94838558 |
| 60 | PIM1 | 0.93205294 |
| 61 | CLK1 | 0.91836650 |
| 62 | RPS6KA4 | 0.91380024 |
| 63 | MAP3K7 | 0.90309096 |
| 64 | LCK | 0.90288714 |
| 65 | MARK3 | 0.89064774 |
| 66 | MTOR | 0.88628548 |
| 67 | JAK2 | 0.86268300 |
| 68 | EPHA3 | 0.84199617 |
| 69 | DYRK1B | 0.83480848 |
| 70 | PDK1 | 0.83040289 |
| 71 | FES | 0.82740708 |
| 72 | DDR2 | 0.80555596 |
| 73 | MARK2 | 0.80378425 |
| 74 | NME2 | 0.79781912 |
| 75 | TESK1 | 0.79300634 |
| 76 | SIK3 | 0.79264048 |
| 77 | MAP3K13 | 0.77945321 |
| 78 | RPS6KA2 | 0.76002336 |
| 79 | CDK4 | 0.74777873 |
| 80 | BRD4 | 0.74640569 |
| 81 | TESK2 | 0.73779064 |
| 82 | PDGFRB | 0.73653732 |
| 83 | MAP2K2 | 0.72657427 |
| 84 | PRKCH | 0.71523717 |
| 85 | IRAK1 | 0.62857224 |
| 86 | STK4 | 0.62837991 |
| 87 | CAMKK1 | 0.61479289 |
| 88 | TYRO3 | 0.60978899 |
| 89 | FGR | 0.60938024 |
| 90 | LYN | 0.59462958 |
| 91 | PAK4 | 0.58376060 |
| 92 | MAP3K11 | 0.58307328 |
| 93 | SGK3 | 0.56584242 |
| 94 | STK38 | 0.54636519 |
| 95 | TNK2 | 0.53963797 |
| 96 | PRKD3 | 0.53882303 |
| 97 | EGFR | 0.53768657 |
| 98 | PRKD1 | 0.53674374 |
| 99 | STK3 | 0.51443370 |
| 100 | MAPKAPK2 | 0.51254167 |
| 101 | RET | 0.51103143 |
| 102 | PDGFRA | 0.50745473 |
| 103 | RPS6KA6 | 0.50407604 |
| 104 | EPHA2 | 0.49943227 |
| 105 | MAPK7 | 0.49590271 |
| 106 | MAP3K1 | 0.49543545 |
| 107 | PTK2 | 0.49409619 |
| 108 | ABL1 | 0.48358892 |
| 109 | MAP3K2 | 0.47785628 |
| 110 | MAPK11 | 0.46946416 |
| 111 | MAP3K8 | 0.46939910 |
| 112 | WNK1 | 0.46843198 |
| 113 | MAP2K3 | 0.45913444 |
| 114 | NLK | 0.45108409 |
| 115 | MAPK15 | 0.44838461 |
| 116 | RPS6KL1 | 0.44675131 |
| 117 | RPS6KC1 | 0.44675131 |
| 118 | MAPK12 | 0.44032995 |
| 119 | MAP3K6 | 0.42731235 |
| 120 | TRPM7 | 0.41735630 |
| 121 | RPS6KA1 | 0.41589145 |
| 122 | MATK | 0.40740531 |
| 123 | NEK2 | 0.39931233 |
| 124 | PAK2 | 0.38370791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.55380881 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.43919958 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42291563 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.32009366 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94074146 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90843361 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.84309822 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81701608 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.75373625 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72977651 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68639944 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65780315 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64932384 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61191237 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48650911 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48477416 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43265315 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42371790 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42044780 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.40557389 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40388667 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38993122 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37801915 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37255107 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36792540 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36288044 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35668203 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35396894 |
| 29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32649452 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.31931757 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.31492547 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31004263 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30939169 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.30767805 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27907967 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.27803583 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.26738412 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23898866 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22985349 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.22702188 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.21631581 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21037662 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20160641 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.17603374 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14200171 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13399764 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.12919186 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12005438 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11564220 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 1.08054783 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07547665 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01796169 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01007952 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00973911 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99258964 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.97009598 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96365552 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96200899 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.94230318 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93658150 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92700246 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92581676 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.91903683 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91567168 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.90473730 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.86395636 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.86242054 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84404730 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.82320563 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82185043 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81474772 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80898034 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.79835017 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78269357 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.77907489 |
| 76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76894164 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76696616 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.74837042 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73824756 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73278224 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.71636204 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71443065 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70680778 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70496331 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70338807 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.69929168 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.68325020 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67335747 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67281167 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66129966 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.63427421 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62183968 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61737717 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61410542 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60641678 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60241467 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59688699 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58483881 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57917076 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57005674 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55614566 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55096408 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54129110 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54100300 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.53879503 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51117769 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50416283 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48138995 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47858464 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47192175 |

